Financial Contrast: Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) vs. Longevity Health (NASDAQ:XAGE)

Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) and Longevity Health (NASDAQ:XAGE) are both small-cap manufacturing companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings.

Insider & Institutional Ownership

12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. Comparatively, 24.2% of Longevity Health shares are held by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are held by company insiders. Comparatively, 29.0% of Longevity Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Profitability

This table compares Inspira Technologies OXY B.H.N. and Longevity Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Inspira Technologies OXY B.H.N.	N/A	N/A	N/A
Longevity Health	-682.67%	N/A	-261.90%

Volatility & Risk

Inspira Technologies OXY B.H.N. has a beta of 4.11, suggesting that its share price is 311% more volatile than the S&P 500. Comparatively, Longevity Health has a beta of 0.38, suggesting that its share price is 62% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current recommendations for Inspira Technologies OXY B.H.N. and Longevity Health, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inspira Technologies OXY B.H.N.	1	0	0	0	1.00
Longevity Health	0	0	0	0	0.00

Valuation and Earnings

This table compares Inspira Technologies OXY B.H.N. and Longevity Health”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inspira Technologies OXY B.H.N.	$290,000.00	249.17	-$13.22 million	N/A	N/A
Longevity Health	$1.05 million	0.55	-$10.37 million	($4.29)	-0.08

Longevity Health has higher revenue and earnings than Inspira Technologies OXY B.H.N..

Summary

Inspira Technologies OXY B.H.N. beats Longevity Health on 6 of the 9 factors compared between the two stocks.

About Inspira Technologies OXY B.H.N.

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra’annana, Israel.

About Longevity Health

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.